RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Procept Biorobotics Stock

Procept Biorobotics Dividend 2024

Procept Biorobotics Dividend

0 USD

Procept Biorobotics Dividend yield

Ticker

PRCT

ISIN

US74276L1052

How much dividend does Procept Biorobotics 2024 pay?

According to the latest status from December 2024, Procept Biorobotics paid a total of 0 USD per share in dividends within the last 12 months. With the current Procept Biorobotics price of 88.56 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Procept Biorobotics Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Procept Biorobotics Dividend Safe?

Procept Biorobotics has been increasing the dividend for 0 years.

Over the past 5 years, Procept Biorobotics has increased it by an annual 0 %.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Procept Biorobotics's Dividend Distributions

Procept Biorobotics’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Procept Biorobotics's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Procept Biorobotics's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Procept Biorobotics’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Procept Biorobotics Aktienanalyse

What does Procept Biorobotics do?

PROCEPT BioRobotics Corp (PROCEPT) is a California-based medical technology company specializing in the development of robotic technologies for urological surgery. History: PROCEPT was founded in 2013 by Dr. Chin and his group at Johns Hopkins University School of Medicine. They developed a novel technology that had the potential to revolutionize the treatment of prostate cancer. PROCEPT used a robust Intuitive Surgical platform and developed a novel tissue classification technology that allows surgeons to operate with accuracy and safety. The first system, called AquaBeam®, was approved by the US Food and Drug Administration (FDA) in 2018 and has since been in use in Europe and the US. Business: PROCEPT aims to improve urological surgery through the use of robotic technologies, thereby increasing patient safety and care. The company focuses on the development and commercialization of robotic systems for the treatment of prostate cancer and other urological diseases. Products: PROCEPT has developed Aquablation®, a robotic system for the treatment of prostate cancer. It is a minimally invasive technology that uses high-precision waterjet cutting (accuracy reduced to millimeters) to remove cancerous tissue quickly, effectively, and accurately. The technology can also be used in surgical procedures on the bladder, urethra, and other urological organs. Divisions: PROCEPT has a broad portfolio of services and products in the field of urological surgery. The AquaBeam® technology is the first system developed to treat malignant prostate tumors using robotic technologies. The technology is used in hospitals, clinics, and medical facilities worldwide. In addition, PROCEPT offers training and support for surgeons and medical personnel. Conclusion: PROCEPT BioRobotics Corp is an emerging medical technology company specializing in robotics-based urological surgery. The AquaBeam® technology is an innovative, robotic technology for the treatment of prostate cancer. The company is on its way to revolutionizing urological surgery and making a significant contribution to improving healthcare. Procept Biorobotics is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Procept Biorobotics stock

How much dividend does Procept Biorobotics pay?

Over the past 12 months, Procept Biorobotics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Procept Biorobotics is expected to pay a dividend of 0 USD.

What is the dividend yield of Procept Biorobotics?

The current dividend yield of Procept Biorobotics is .

When does Procept Biorobotics pay dividends?

Procept Biorobotics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Procept Biorobotics?

Procept Biorobotics paid dividends every year for the past 0 years.

What is the dividend of Procept Biorobotics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Procept Biorobotics located?

Procept Biorobotics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Procept Biorobotics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Procept Biorobotics from 12/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.

When did Procept Biorobotics pay the last dividend?

The last dividend was paid out on 12/18/2024.

What was the dividend of Procept Biorobotics in the year 2023?

In the year 2023, Procept Biorobotics distributed 0 USD as dividends.

In which currency does Procept Biorobotics pay out the dividend?

The dividends of Procept Biorobotics are distributed in USD.

Andere Kennzahlen von Procept Biorobotics

Our stock analysis for Procept Biorobotics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Procept Biorobotics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.